ARECOR THERAPEUTICS PLC — Investor Relations & Filings
Arecor Therapeutics plc is a clinical-stage biopharmaceutical company focused on developing enhanced therapeutic medicines. The company utilizes its proprietary Arestat® technology platform, a formulation science designed to improve the properties of proteins and peptides, enabling superior drug product profiles. Arecor's business model involves two approaches: developing an internal portfolio of proprietary products and partnering with pharmaceutical and medtech companies to enhance their therapeutic offerings. The company's in-house development pipeline is primarily focused on advancing treatments for diabetes and other cardiometabolic diseases, including next-generation insulin candidates.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Interim results for the six months to 30 June 2025 | 2025-09-25 | English | |
| Co-Development Agreement & Monetisation Deal | 2025-09-25 | English | |
| Notice of Interim Results | 2025-09-24 | English | |
| Positive FDA Feedback on Phase 2 Study Design | 2025-09-04 | English | |
| Holding(s) in Company | 2025-08-28 | English | |
| Change of Auditor | 2025-08-08 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 11390465 | Interim results for the six months to 30 June 2025 | 2025-09-25 | English | ||
| 11390352 | Co-Development Agreement & Monetisation Deal | 2025-09-25 | English | ||
| 7925061 | Notice of Interim Results | 2025-09-24 | English | ||
| 7778202 | Positive FDA Feedback on Phase 2 Study Design | 2025-09-04 | English | ||
| 7772275 | Holding(s) in Company | 2025-08-28 | English | ||
| 7658618 | Change of Auditor | 2025-08-08 | English | ||
| 6952121 | Arecor Establishes New Scientific Advisory Board | 2025-07-14 | English | ||
| 11360995 | Grant of Options and PDMR Dealing | 2025-06-04 | English | ||
| 6105253 | Result of AGM | 2025-06-02 | English | ||
| 6088518 | Non-Executive Director Board Change | 2025-06-02 | English | ||
| 11357095 | Director/PDMR Dealing | 2025-05-21 | English | ||
| 11355553 | Arecor Partnership with Skye Bioscience | 2025-05-19 | English | ||
| 11354672 | Director Dealing | 2025-05-14 | English | ||
| 46835175 | Group of companies' accounts made up to 2024-12-31 | 2025-05-13 | English | ||
| 11351620 | Arecor sells rights to non-Ogluo® products | 2025-05-08 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for ARECOR THERAPEUTICS PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
ARECOR THERAPEUTICS PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/7494/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=7494 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=7494 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=7494 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 7494}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ARECOR THERAPEUTICS PLC (id: 7494)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.